184 related articles for article (PubMed ID: 25384540)
1. Huge kidneys in a patient with chronic lymphocytic leukaemia.
Esposito P; Libetta C; Rampino T; Gregorini M; Margiotta E; Dal Canton A
Br J Haematol; 2015 Feb; 168(4):470. PubMed ID: 25384540
[No Abstract] [Full Text] [Related]
2. Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature.
Uprety D; Peterson A; Shah BK
Ann Hematol; 2013 Jan; 92(2):271-3. PubMed ID: 22875063
[No Abstract] [Full Text] [Related]
3. [Leukaemia cutis: clinical manifestation of chronic lymphocytic leukaemia relapse].
Sureda NC; Bosch MP; Kurpis M; Ruiz Lascano A
Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(1):42-4. PubMed ID: 18426096
[TBL] [Abstract][Full Text] [Related]
4. Renal dysfunction due to leukemic infiltration of kidneys in a case of chronic lymphocytic leukemia.
Ferreira AC; Brum S; Carvalho D; Pataca I; Carvalho F; Santos MC; Santos JR
Hemodial Int; 2010 Jan; 14(1):87-90. PubMed ID: 19758305
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine in CLL: How quickly will today's consensus become tomorrow's memory?
Cheson BD
Leuk Res; 2014 Nov; 38(11):1267-8. PubMed ID: 25260826
[No Abstract] [Full Text] [Related]
6. Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients.
Montillo M; Tedeschi A; Gaidano G; Coscia M; Petrizzi VB; Orlandi E; Cascavilla N; Ghia P; Motta M; Gallamini A; Frustaci AM; Rossi D; De Paoli L; Nichelatti M; Morra E; Massaia M
Haematologica; 2014 Sep; 99(9):e159-61. PubMed ID: 24972768
[No Abstract] [Full Text] [Related]
7. The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD).
Shoji J; Lew SQ
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645657
[TBL] [Abstract][Full Text] [Related]
8. [Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
Aymard B; Beghoura R; Molina TJ
Nephrol Ther; 2011 Nov; 7(6):479-87. PubMed ID: 21439927
[TBL] [Abstract][Full Text] [Related]
9. Renal failure due to T-cell mediated lymphocytic vasculitis: an unusual complication of B-cell chronic lymphocytic leukemia.
Quenneville LA; Magil AB
Am J Kidney Dis; 2000 Sep; 36(3):E17. PubMed ID: 10977810
[TBL] [Abstract][Full Text] [Related]
10. Bendamustine.
Keating MJ; Bach C; Yasothan U; Kirkpatrick P
Nat Rev Drug Discov; 2008 Jun; 7(6):473-4. PubMed ID: 18511926
[No Abstract] [Full Text] [Related]
11. The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.
Nordstrom BL; Knopf KB; Teltsch DY; Engle R; Beygi H; Sterchele JA
Leuk Lymphoma; 2014 Jun; 55(6):1266-73. PubMed ID: 23987821
[TBL] [Abstract][Full Text] [Related]
12. Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group.
Cuneo A; Marchetti M; Barosi G; Billio A; Brugiatelli M; Ciolli S; Laurenti L; Mauro FR; Molica S; Montillo M; Zinzani P; Tura S
Leuk Res; 2014 Nov; 38(11):1269-77. PubMed ID: 25063524
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia.
Haskova Z; Whitacre MN; Dede KA; Lee JM; Trulli SH; Ciucci M; Toso JF; White JR; Jonak ZL
Br J Haematol; 2012 Feb; 156(3):402-4. PubMed ID: 21848524
[No Abstract] [Full Text] [Related]
14. Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
Zaja F; Mian M; Volpetti S; Visco C; Sissa C; Nichele I; Castelli M; Ambrosetti A; Puglisi S; Fanin R; Cortelazzo S; Pizzolo G; Trentin L; Rodeghiero F; Paolini R; Vivaldi P; Sancetta R; Isola M; Semenzato G
Am J Hematol; 2013 Nov; 88(11):955-60. PubMed ID: 23861234
[TBL] [Abstract][Full Text] [Related]
15. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
[No Abstract] [Full Text] [Related]
16. Reversible renal failure due to specific infiltration of the kidney in chronic lymphocytic leukaemia.
Comerma-Coma MI; Sans-Boix A; Tuset-Andújar E; Andreu-Navarro J; Pérez-Ruiz A; Naval-Marcos I
Nephrol Dial Transplant; 1998 Jun; 13(6):1550-2. PubMed ID: 9641192
[No Abstract] [Full Text] [Related]
17. Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab-bendamustine.
García-Muñoz R; García DK; Roldán-Galiacho V; Merchante-Andreu M; Campeny-Najara A; Rabasa P
Ann Hematol; 2014 Apr; 93(4):699-702. PubMed ID: 23907409
[No Abstract] [Full Text] [Related]
18. Therapeutic targets in the nitrogen mustard sensitivity of B-cell chronic lymphocyte leukemia (B-CLL).
Kannan S
Med Hypotheses; 2006; 67(4):998. PubMed ID: 16757124
[No Abstract] [Full Text] [Related]
19. Bendamustine for treatment of chronic lymphocytic leukemia.
Chang JE; Kahl BS
Expert Opin Pharmacother; 2012 Jul; 13(10):1495-505. PubMed ID: 22663160
[TBL] [Abstract][Full Text] [Related]
20. Bendamustine: inadequate or outdated data.
Prescrire Int; 2012 Mar; 21(125):64. PubMed ID: 22428184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
